T. Rowe Price Associates
TWST icon

T. Rowe Price Associates’s Twist Bioscience TWST Stock Holding History

T. Rowe Price Associates’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34M Buy
70,305
+11,320
+19% +$508K ﹤0.01% 1604
2025
Q4 		$1.87M Buy
58,985
+5,135
+10% +$160K ﹤0.01% 1784
2025
Q3 		$1.52M Buy
53,850
+4,566
+9% +$138K ﹤0.01% 1863
2025
Q2 		$1.81M Buy
49,284
+3,527
+8% +$122K ﹤0.01% 1681
2025
Q1 		$1.8M Buy
45,757
+4,356
+11% +$196K ﹤0.01% 1653
2024
Q4 		$1.92M Buy
41,401
+5,554
+15% +$251K ﹤0.01% 1667
2024
Q3 		$1.62M Buy
35,847
+1,100
+3% +$52.3K ﹤0.01% 1740
2024
Q2 		$1.71M Buy
34,747
+2,620
+8% +$107K ﹤0.01% 1633
2024
Q1 		$1.1M Buy
32,127
+2,292
+8% +$82.7K ﹤0.01% 1870
2023
Q4 		$1.1M Sell
29,835
-530,122
-95% -$12.3M ﹤0.01% 1826
2023
Q3 		$11.3M Sell
559,957
-21,683
-4% -$476K ﹤0.01% 1055
2023
Q2 		$11.9M Buy
581,640
+180,411
+45% +$2.7M ﹤0.01% 1049
2023
Q1 		$6.05M Sell
401,229
-323,023
-45% -$7.14M ﹤0.01% 1141
2022
Q4 		$17.2M Sell
724,252
-86,971
-11% -$2.52M ﹤0.01% 951
2022
Q3 		$28.6M Sell
811,223
-447,171
-36% -$19M ﹤0.01% 798
2022
Q2 		$44M Buy
1,258,394
+120,489
+11% +$4.27M 0.01% 915
2022
Q1 		$56.2M Buy
1,137,905
+222,676
+24% +$12.3M 0.01% 932
2021
Q4 		$70.8M Sell
915,229
-123,529
-12% -$12.7M 0.01% 877
2021
Q3 		$111M Sell
1,038,758
-5,998
-0.6% -$687K 0.01% 732
2021
Q2 		$139M Buy
1,044,756
+86,849
+9% +$10.1M 0.01% 671
2021
Q1 		$119M Sell
957,907
-13,070
-1% -$1.98M 0.01% 720
2020
Q4 		$137M Buy
970,977
+317,301
+49% +$35.2M 0.01% 622
2020
Q3 		$49.7M Buy
653,676
+174,094
+36% +$10.8M 0.01% 874
2020
Q2 		$21.7M Buy
479,582
+472,790
+6,961% +$17M ﹤0.01% 1120
2020
Q1 		$208K Buy
+6,792
New +$183K ﹤0.01% 2307

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates's TWST Position: Q1 2026 in Review

T. Rowe Price Associates increased its Twist Bioscience (TWST) stake by 19% in Q1 2026, buying an estimated $508K and bringing the position to 70,305 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

T. Rowe Price Associates first reported a position in TWST in Q1 2020 and has held it in 25 quarters since. The position peaked at $139M in Q2 2021. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • T. Rowe Price Associates held 70,305 shares of Twist Bioscience worth $3.34M as of Q1 2026.
  • T. Rowe Price Associates bought 11,320 Twist Bioscience shares in Q1 2026, an estimated $508K.
  • Twist Bioscience made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1604 holding.
  • T. Rowe Price Associates first reported a position in Twist Bioscience in Q1 2020 and has held it in 25 quarters since.
  • T. Rowe Price Associates's Twist Bioscience position peaked at $139M in Q2 2021.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.